Shandong Kexing Bioproducts Co., Ltd.
Exhibitor at CPhI Worldwide 2019 stand 61D66, API
Shandong Kexing Bioproducts integrates R&D, manufacture, and sales of biopharmaceuticals.
Its production site offers Recombinant Human Erythropoietin Injection(EPO), Recombinant Human Granulocyte Colony-stimulating Factor Injection(rh-G-CSF)Filgrastim, and Combined Clostridium Butyricum and Bifidobacterium Powders, Live for clinical and commercial use. I
The company develops recombinant genetic biological drugs and micro-ecological preparation, to serve the clinical treatment needs of kidney diseases, tumor, and gastrointestinal diseases. It has become a leading player in China's biopharmaceutical industry after more than 20 years of development.
- No.1 Chinese producer of Recombinant Human Erythropoietin Injection(CHO Cell)
- One of leading bio-pharmaceutical suppliers in China
- EPSINO is the first EPO Product put in Chinese market
- The only EPO product free of huma
Specs about this supplier
|Sales markets||Eastern Europe; Middle East; Asia; Africa; Central/South America|
|Affiliated categories:||Biopharmaceuticals (general category) |Injectables |Parenterals More|
Products featured at CPhI Worldwide 2019
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation